Effectiveness of Pharmacopuncture for Chronic Neck Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-18

Study Completion Date

2020-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators will evaluate the efficacy and safety of pharmacopuncture therapy for chronic neck pain compared to physical therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PCT of Pharmacopuncture for Chronic Neck Pain

NCT06520462

Neck Pain Chronic Pain

RECRUITING NA

The Effectiveness and Cost-effectiveness of Motion Style Acupuncture Treatment (MSAT) for Acute Neck Pain: A Multi-center Randomized Controlled Trial

NCT04539184

Acute Neck Pain

COMPLETED NA

Effectiveness of Dry Needling of Active Trigger Points in Neck Muscles in Patients With Chronic Cervical Pain

NCT06257992

Cervical Pain

NOT_YET_RECRUITING NA

Dry Needling With Percutaneous Electrical Nerve Stimulation and Exercises for Non-specific Chronic Neck Pain

NCT07015281

Neck Pain

ACTIVE_NOT_RECRUITING NA

Effectiveness of Dry Needling and Ischemic Compression in Sternocleidomastoid, on Cervical Motor Control in Patients With Cervical Pain.

NCT03331653

Cervical Pain

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is prgmatic RCT of pharmacopuncture therapy for chronic neck pain compared to physical therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Neck Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pharmacopuncture therapy

The physicians will select one or more pharmacopuncture therapy for each participants. The physicians will also decide dosage and frequency of treatment according to the participant's status.

Group Type EXPERIMENTAL

pharmacopuncture therapy

Intervention Type PROCEDURE

The participants in the treatment group will be receive one or more pharmacopuncture therapy according to the physician's decision.

physical therapy

The physicians will select one or more physical therapy for each participants. The physicians will also decide intensity and frequency of treatment according to the participant's status.

Group Type ACTIVE_COMPARATOR

Physical therapy

Intervention Type PROCEDURE

The participants in the control group will be receive one or more physical therapy according to the physician's decision.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pharmacopuncture therapy

The participants in the treatment group will be receive one or more pharmacopuncture therapy according to the physician's decision.

Intervention Type PROCEDURE

Physical therapy

The participants in the control group will be receive one or more physical therapy according to the physician's decision.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neck pain more than 6 months
* VAS of neck pain more than 5
* Age between 17 and 70 years old
* Participants who wrote informed consent

Exclusion Criteria

* Migration of cancer reaching to spine, fracture of spine
* Progressive neurologic deficits or severe neurologic deficits
* Cancer, fibromyalgia, RA, or goat
* Stroke, MI, kidney disease, dimentia, diabetic neuropathy, or epilepsy
* Participants taking steroid, immunosuppressant, or psychotropic medication
* Hemorrhagic disease, severe diabetes or taking anticoagulant drug
* Participants who took NSAIDs or pharmacopuncture within 1 week
* Pregnant or lactating women
* Participants who had undergone cervical surgery within 3 months
* Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial
* Participants who can not write informed consent
* Participants who is difficult to participate in the trial according to investigator's decision

Minimum Eligible Age

19 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes